argenx SE (ARGX): Price and Financial Metrics
argenx SE (ARGX)
Today's Latest Price: $148.20 USD
1.42 (-0.95%)
Updated Dec 6 10:28am
Add ARGX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ARGX Stock Summary
- The ratio of debt to operating expenses for Argenx Se is higher than it is for about merely 0.39% of US stocks.
- With a price/sales ratio of 188.12, Argenx Se has a higher such ratio than 98.7% of stocks in our set.
- Over the past twelve months, ARGX has reported earnings growth of 191.72%, putting it ahead of 93.39% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Argenx Se, a group of peers worth examining would be FATE, FIXX, SNDX, ALPN, and ANAB.
- Visit ARGX's SEC page to see the company's official filings. To visit the company's web site, go to www.argenx.com.
ARGX Daily Price Range
ARGX 52-Week Price Range
ARGX Stock Price Chart More Charts
ARGX Price/Volume Stats
| Current price | $148.20 |
| Prev. close | $149.62 |
| Day low | $147.71 |
| Day high | $149.38 |
| 50-day MA | $126.53 |
| 200-day MA | $129.82 |
| 52-week high | $152.01 |
| 52-week low | $88.05 |
| Volume | 34,185 |
| Avg. volume | 167,631 |
| Dividend yield | N/A |
| Market Cap | 5.65B |
argenx SE (ARGX) Company Bio
arGEN-X N.V., a clinical-stage biopharmaceutical company, focuses on creating and developing therapeutic antibodies for the treatment of cancer and autoimmune diseases. The company was founded in 2008 and is based in Breda, Netherlands.
Top Stories View All
Best & Worst Performing Stock Industries for December 5, 2019
Best & Worst Performing Small Cap Stocks for December 5, 2019
Best & Worst Performing Mid Cap Stocks for December 5, 2019
Best & Worst Performing Large Cap Stocks for December 5, 2019
Best & Worst Performing Mega Cap Stocks for December 5, 2019
View All Top Stories
Loading social stream, please wait...